Zhang L & Wu Z. (2023). Adalimumab for Sintilimab-Induced Toxic Epidermal Necrolysis in a Patient with Metastatic Gastric Malignancy: A Case Report and Literature Review. Dove Medical Press.
Chicago Style (17th ed.) CitationZhang L and Wu Z. Adalimumab for Sintilimab-Induced Toxic Epidermal Necrolysis in a Patient with Metastatic Gastric Malignancy: A Case Report and Literature Review. Dove Medical Press, 2023.
MLA (9th ed.) CitationZhang L and Wu Z. Adalimumab for Sintilimab-Induced Toxic Epidermal Necrolysis in a Patient with Metastatic Gastric Malignancy: A Case Report and Literature Review. Dove Medical Press, 2023.
Warning: These citations may not always be 100% accurate.